Notice2022-02330
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 4, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 24 (Friday, February 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6615-6616]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose
[[Page 6616]]
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Clinical Oncology Study Section.
Date: February 28-March 1, 2022.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer,
National Institute of Health, Center for Scientific Review, 6701
Rockville Drive, Room 6200, MSC 7804, Bethesda, MD 20892, (301) 443-
1196, <a href="/cdn-cgi/l/email-protection#a5c9c4d0d7c48bc4d6cbc4c2cdcce5cbcccd8bc2cad3"><span class="__cf_email__" data-cfemail="fa969b8f889bd49b89949b9d9293ba949392d49d958c">[email protected]</span></a>.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Healthcare and Health Disparities Study
Section.
Date: March 3-4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D., Scientific Review
Officer, Center for Scientific of Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301-
827-4446, <a href="/cdn-cgi/l/email-protection#b4d6d1d8d8dddad3d1c6ded0f4d7c7c69adadddc9ad3dbc2"><span class="__cf_email__" data-cfemail="b1d3d4ddddd8dfd6d4c3dbd5f1d2c2c39fdfd8d99fd6dec7">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Risks, Prevention and Health Behavior.
Date: March 3-4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Martha M. Faraday, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD
20892, (301) 435-3575, <a href="/cdn-cgi/l/email-protection#1b7d7a697a7f7a62765b78686935757273357c746d"><span class="__cf_email__" data-cfemail="c8aea9baa9aca9b1a588abbbbae6a6a1a0e6afa7be">[email protected]</span></a>.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Lifestyle Change and Behavioral Health
Study Section.
Date: March 3-4, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pamela Jeter, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockledge Drive, Room 10J08, Bethesda, MD 20892, (301) 827-6401,
<a href="/cdn-cgi/l/email-protection#7202131f171e135c1817061700321c1b1a5c151d04"><span class="__cf_email__" data-cfemail="4636272b232a27682c2332233406282f2e68212930">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR21-326: Modern Equipment for Shared-Use Biomedical
Research Facilities: Advancing Research-Related Operations.
Date: March 3-4, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Michael Peterson, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
<a href="/cdn-cgi/l/email-protection#98f2f7f6f9ecf0f9f6b6e8fdecfdeaebf7f6d8f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="e58f8a8b84918d848bcb9580918097968a8ba58b8c8dcb828a93">[email protected]</span></a>.
Name of Committee: Cell Biology Integrated Review Group;
Cellular Signaling and Regulatory Systems Study Section.
Date: March 3-4, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, 301-435-1022, <a href="/cdn-cgi/l/email-protection#ddbfbcb1bcaea8b3b9bcafbcb0b99dbeaeaff3b3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="056764696476706b616477646861456676772b6b6c6d2b626a73">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Motivated Behavior, Alcohol and
Neurotoxicology.
Date: March 9, 2022.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD
20892, 301-435-1119, <a href="/cdn-cgi/l/email-protection#a0d3c5cccdc1cecfcde0c3d3d28ecec9c88ec7cfd6"><span class="__cf_email__" data-cfemail="f784929b9a9699989ab7948485d9999e9fd9909881">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Pain, Chemosensation and Sensory Motor
Neurobiology.
Date: March 10, 2022.
Time: 10:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Roger Janz, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515,
<a href="/cdn-cgi/l/email-protection#b0dad1decac282f0d3c3c29eded9d89ed7dfc6"><span class="__cf_email__" data-cfemail="69030807131b5b290a1a1b47070001470e061f">[email protected]</span></a>.
Name of Committee: Infectious Diseases and Immunology A
Integrated Review Group; HIV Molecular Virology, Cell Biology, and
Drug Development Study Section.
Date: March 14-15, 2022.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD
20892, (301) 435-1166, <a href="/cdn-cgi/l/email-protection#aedcc1cbccdbcdc5c5eecddddc80c0c7c680c9c1d8"><span class="__cf_email__" data-cfemail="ed9f82888f988e8686ad8e9e9fc3838485c38a829b">[email protected]</span></a>.
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; HIV Comorbidities and Clinical Studies
Study Section.
Date: March 15-16, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David C. Chang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-0290,
<a href="/cdn-cgi/l/email-protection#402328212e27242123002d21292c6e2e29286e272f36"><span class="__cf_email__" data-cfemail="f7949f969990939694b79a969e9bd9999e9fd9909881">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02330 Filed 2-3-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.